GAMMA Investing LLC Purchases 668,165 Shares of Relx Plc (NYSE:RELX)

GAMMA Investing LLC boosted its position in Relx Plc (NYSE:RELX - Free Report) by 6,125.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 679,073 shares of the technology company's stock after buying an additional 668,165 shares during the quarter. GAMMA Investing LLC's holdings in Relx were worth $34,232,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Private Trust Co. NA increased its position in shares of Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after purchasing an additional 199 shares during the last quarter. Sage Mountain Advisors LLC increased its position in shares of Relx by 5.1% during the 4th quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock worth $240,000 after purchasing an additional 258 shares during the last quarter. DRW Securities LLC increased its position in shares of Relx by 5.9% during the 4th quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock worth $211,000 after purchasing an additional 259 shares during the last quarter. Kovitz Investment Group Partners LLC increased its position in shares of Relx by 3.4% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company's stock worth $371,000 after purchasing an additional 267 shares during the last quarter. Finally, Ascent Group LLC increased its position in shares of Relx by 2.0% during the 4th quarter. Ascent Group LLC now owns 14,024 shares of the technology company's stock worth $637,000 after purchasing an additional 277 shares during the last quarter. Institutional investors and hedge funds own 15.02% of the company's stock.

Relx Stock Performance

Shares of NYSE RELX traded down $0.61 during midday trading on Thursday, hitting $53.75. 2,057,397 shares of the company's stock were exchanged, compared to its average volume of 730,369. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. Relx Plc has a 12 month low of $43.45 and a 12 month high of $56.33. The company's 50 day moving average price is $52.53 and its 200 day moving average price is $49.60. The firm has a market capitalization of $99.23 billion, a PE ratio of 28.90, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Wall Street Zen lowered Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. The Goldman Sachs Group initiated coverage on Relx in a research note on Wednesday, March 26th. They set a "buy" rating for the company. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy".

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.